GHRELIN (RAT) | CAS:258338-12-4

We serve GHRELIN (RAT) CAS:258338-12-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
GHRELIN (RAT)

Chemical Name:GHRELIN (RAT)
CAS.NO:258338-12-4
Synonyms:GHRELIN (RAT)
ghrelin,rat
 
Physical and Chemical Properties:
Density 1.5±0.1 g/cm3
Molecular Formula C147H245N45O42
Molecular Weight 3314.794
Index of Refraction 1.667
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Endogenous agonist peptide for the ghrelin receptor (GHS-R1a). Produced mainly by the stomach, it stimulates release of growth hormone from the pituitary gland in vitro and in vivo, and regulates feeding, growth and energy production.



Contact us for information like GHRELIN (RAT) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ghrelin,rat physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,GHRELIN (RAT) Use and application,ghrelin,rat technical grade,usp/ep/jp grade.


Related News: Taiwan previously participated as an observer at the World Health Assembly, the W.H.O.’s governing body.3-(4-Fluorophenyl)-1-isopropyl-1H-indole manufacturer Could a traditional Chinese medicine help fight the Wuhan coronavirus, or is one of the country’s most influential state media outlets promoting pseudoscience and false hope?2,2-Dimethoxy-2-phenylacetophenone supplier Could a traditional Chinese medicine help fight the Wuhan coronavirus, or is one of the country’s most influential state media outlets promoting pseudoscience and false hope?2,4-Dichlorobenzoic Acid vendor “No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,” said Kristen Devito, Global Director, Catalent Clinical Supply Services.“No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,” said Kristen Devito, Global Director, Catalent Clinical Supply Services.